chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 3.0
Sex: F
Vaccine: FLUN(H1N1), FLUX(H1N1), FLU3
Symptoms: Acoustic stimulation tests normal, Speech disorder, Thinking abnormal
Clinical narrative: Initial report received on 11 May 2010 from a health care professional. Follow-up information was received via a follow-up telephone call initiated by the manufacturer to the reporter on 12 May 2010. A 3-year-old female patient had possibly received a dose of H1N1 on an unspecified date. The reporter was unsure if the patient's mother was referring to the FLUZONE given on 27 October 2009 or if the patient received an H1N1 elsewhere and experienced the events described. The trade name, manufacturer name, lot number, route and site of administration were unknown for the H1N1. In December 2009, the patient was seen by her pediatrician for another reason, and at that time the mother reported that 2 weeks after receiving a H1N1 the patient developed speech and language comprehension issues. The mother reported the patient had been evaluated by a specialist several times; however results of those evaluations were not reported. It was unknown if the patient had any diagnostic tests or laboratory data completed. It was noted the patient had previously received a third intramuscular left thigh injection of FLUZONE (lot number U3263DA) on 27 October 2009 where she developed hives that lasted for 2 weeks. This event is reported in case number 2010-02714. Patient medical history includes no concurrent illnesses, no known allergies and no use of other medications at time of vaccination with H1N1. It was also reported the patient had no adverse events associated with any vaccinations received prior to 27 October 2009. At the time of this report, the patient had not recovered.
Age: 3.0
Sex: F
Vaccine: FLUN(H1N1), FLUX(H1N1), FLU3
Symptoms: No reaction on previous exposure to drug, Speech disorder developmental, Urticaria
Clinical narrative: Initial report received on 11 May 2010 from a health care professional. Follow-up information was received via a follow-up telephone call initiated by the manufacturer to the reporter on 12 May 2010. A 3-year-old female patient had possibly received a dose of H1N1 on an unspecified date. The reporter was unsure if the patient's mother was referring to the FLUZONE given on 27 October 2009 or if the patient received an H1N1 elsewhere and experienced the events described. The trade name, manufacturer name, lot number, route and site of administration were unknown for the H1N1. In December 2009, the patient was seen by her pediatrician for another reason, and at that time the mother reported that 2 weeks after receiving a H1N1 the patient developed speech and language comprehension issues. The mother reported the patient had been evaluated by a specialist several times; however results of those evaluations were not reported. It was unknown if the patient had any diagnostic tests or laboratory data completed. It was noted the patient had previously received a third intramuscular left thigh injection of FLUZONE (lot number U3263DA) on 27 October 2009 where she developed hives that lasted for 2 weeks. This event is reported in case number 2010-02714. Patient medical history includes no concurrent illnesses, no known allergies and no use of other medications at time of vaccination with H1N1. It was also reported the patient had no adverse events associated with any vaccinations received prior to 27 October 2009. At the time of this report, the patient had not recovered.
Age: 3.0
Sex: F
Vaccine: FLUN(H1N1), FLUX(H1N1), FLU3
Symptoms: Speech disorder developmental, Urticaria
Clinical narrative: Initial report received on 11 May 2010 from a health care professional. Follow-up information was received via a follow-up telephone call initiated by the manufacturer to the reporter on 12 May 2010. A 3-year-old female patient had possibly received a dose of H1N1 on an unspecified date. The reporter was unsure if the patient's mother was referring to the FLUZONE given on 27 October 2009 or if the patient received an H1N1 elsewhere and experienced the events described. The trade name, manufacturer name, lot number, route and site of administration were unknown for the H1N1. In December 2009, the patient was seen by her pediatrician for another reason, and at that time the mother reported that 2 weeks after receiving a H1N1 the patient developed speech and language comprehension issues. The mother reported the patient had been evaluated by a specialist several times; however results of those evaluations were not reported. It was unknown if the patient had any diagnostic tests or laboratory data completed. It was noted the patient had previously received a third intramuscular left thigh injection of FLUZONE (lot number U3263DA) on 27 October 2009 where she developed hives that lasted for 2 weeks. This event is reported in case number 2010-02714. Patient medical history includes no concurrent illnesses, no known allergies and no use of other medications at time of vaccination with H1N1. It was also reported the patient had no adverse events associated with any vaccinations received prior to 27 October 2009. At the time of this report, the patient had not recovered.
Age: 0.59
Sex: M
Vaccine: DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13
Symptoms: Death
Clinical narrative: Information regarding PREVNAR 13 was received from a healthcare professional regarding a 7-month-old male patient who died due to an unknown cause. At 7 months of age, the patient received the first dose on 07-May-2010. Additional suspect medication included PENTACEL. After receiving vaccinations with PREVNAR 13 and PENTACEL on 07-May-2010, the patient was taken home and given a nap. However, the patient died during his nap from an unknown cause of death. The parents called for emergency medical services personnel (EMS). However, the patient was already dead when the EMS arrived. The patient was not transported to an emergency room or admitted to a hospital. It was not known how long after the patient received his vaccines that he died. An autopsy was conducted on an unspecified date in May-2010 but the results were not yet known at the time of this reporting. No additional information was available at the time of this report.
Age: 0.59
Sex: M
Vaccine: DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13, DTAPIPVHIB, PNC13
Symptoms: Autopsy, Death
Clinical narrative: Information regarding PREVNAR 13 was received from a healthcare professional regarding a 7-month-old male patient who died due to an unknown cause. At 7 months of age, the patient received the first dose on 07-May-2010. Additional suspect medication included PENTACEL. After receiving vaccinations with PREVNAR 13 and PENTACEL on 07-May-2010, the patient was taken home and given a nap. However, the patient died during his nap from an unknown cause of death. The parents called for emergency medical services personnel (EMS). However, the patient was already dead when the EMS arrived. The patient was not transported to an emergency room or admitted to a hospital. It was not known how long after the patient received his vaccines that he died. An autopsy was conducted on an unspecified date in May-2010 but the results were not yet known at the time of this reporting. No additional information was available at the time of this report.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: See previous page for Shingles outbreaks...several since getting Zoster Vaccine -- AFTER one year post-shot.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Patient experienced redness at injection site that persisted a week after vaccination.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV4, MEN, TDAP
Symptoms: Injection site erythema, Injection site nodule, Injection site pain
Clinical narrative: Received Tdap on 5/3/10.  On 5/5/10 site began to get red (size of baseball) and knot under injection site size of a quarter.  Pain when touching site.
Age: 1.33
Sex: M
Vaccine: DTAPIPVHIB, MMR
Symptoms: Full blood count, Metabolic function test, Occult blood, Oedema peripheral, Pyrexia
Clinical narrative: Whole body rash fever (102). Swollen hands, feet and legs.
Age: 1.33
Sex: M
Vaccine: DTAPIPVHIB, MMR
Symptoms: Rash generalised
Clinical narrative: Whole body rash fever (102). Swollen hands, feet and legs.
Age: 1.53
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Rash, fever.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site reaction
Clinical narrative: Redness to site, no swelling more a local reaction, hurt a little to touch.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Gait disturbance, Injection site swelling
Clinical narrative: Patient's (L) thigh became swollen and developed limp. No redness or warmth to thigh.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Cough, Dysphonia
Clinical narrative: Hoarseness, Coughing. Given Claritin 10 mg by mouth 5/21/10 10:00 am w/instructions to take 1 tab by mouth every day x 2 more & to ER if condition worsens.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash papular
Clinical narrative: Several red spots, some elevated, no pustules, on L side of chest, front and back, mostly on site of previous mastectomy, itching at first, then subsided.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Activities of daily living impaired, Diarrhoea, Headache, Injection site mass, Injection site urticaria
Clinical narrative: Sunday 16th noticed lump and hives at the injection site around noon, c/o temporal headache off and on for the past 5 days at times becoming severe. Vomited 1x @ approx 8-9pm on Monday the 17th. Tuesday the 18th had diarrhea. Wednesday 19th left school early due to headache and above listed symptoms, taken to MD, neuro assessment completed = nothing abnormal detected. No fever, no muscle weakness, appetite is unchanged. NO C/O headache this AM 21st prior to leaving for school.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Neurological examination normal, Vomiting
Clinical narrative: Sunday 16th noticed lump and hives at the injection site around noon, c/o temporal headache off and on for the past 5 days at times becoming severe. Vomited 1x @ approx 8-9pm on Monday the 17th. Tuesday the 18th had diarrhea. Wednesday 19th left school early due to headache and above listed symptoms, taken to MD, neuro assessment completed = nothing abnormal detected. No fever, no muscle weakness, appetite is unchanged. NO C/O headache this AM 21st prior to leaving for school.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Abdominal pain upper, Asthenia, Back pain, Blood test normal, Diet refusal
Clinical narrative: Severe headache, neck and lower back pain, vomiting, unable to eat, muscle cramps in legs, unable to move arms and shoulders, stomach pain, slight rash on chest and back, very weak, and unable to stay awake. Symptoms worsened through the day.  I contacted the school nurse at noon, then patient's DR at 1:30.  I was told by DR to take him to the ER.  An IV and pain meds were administered.  We were home by 5pm, he was feeling better and was able to eat a sandwich and went back to sleep for the night.  He continued to have pain especially in the neck and arms, ibuprofen was given. He is still at home with pain and weakness, but feeling better.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Headache, Hypersomnia, Movement disorder, Muscle spasms, Neck pain
Clinical narrative: Severe headache, neck and lower back pain, vomiting, unable to eat, muscle cramps in legs, unable to move arms and shoulders, stomach pain, slight rash on chest and back, very weak, and unable to stay awake. Symptoms worsened through the day.  I contacted the school nurse at noon, then patient's DR at 1:30.  I was told by DR to take him to the ER.  An IV and pain meds were administered.  We were home by 5pm, he was feeling better and was able to eat a sandwich and went back to sleep for the night.  He continued to have pain especially in the neck and arms, ibuprofen was given. He is still at home with pain and weakness, but feeling better.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Rash, Vomiting
Clinical narrative: Severe headache, neck and lower back pain, vomiting, unable to eat, muscle cramps in legs, unable to move arms and shoulders, stomach pain, slight rash on chest and back, very weak, and unable to stay awake. Symptoms worsened through the day.  I contacted the school nurse at noon, then patient's DR at 1:30.  I was told by DR to take him to the ER.  An IV and pain meds were administered.  We were home by 5pm, he was feeling better and was able to eat a sandwich and went back to sleep for the night.  He continued to have pain especially in the neck and arms, ibuprofen was given. He is still at home with pain and weakness, but feeling better.
Age: 1.6
Sex: F
Vaccine: HEPA, PNC13
Symptoms: Body temperature increased
Clinical narrative: Temperature increasing up to 103 degrees.  Ibuprofen & Tylenol every 4 hours.  Make child comfortable, keep her cool.
Age: 50.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pain
Clinical narrative: Patient receive the vaccine Tuesday afternoon and by Wednesday morning had red streaks down his arm. Report to primary care provider and was told that if it did not apporoved by Friday report to urgent care. Urgent Care Nurse report localized redness and swelling at the injection site and the patient expressed his arm was aching at a 3 pain level.
Age: 5.0
Sex: F
Vaccine: DTP, IPV, MMR, VARCEL
Symptoms: Oedema peripheral
Clinical narrative: Left leg swollen a little.
Age: 2.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Day of vaccines - right upper arm red, firm, warm to touch, resolved 5/14/10 - no fever.
Age: 36.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema
Clinical narrative: (MENACTRA) Erythema 6cm x 5cm R deltoid. No fevers. No treatment done.
Age: 13.0
Sex: F
Vaccine: PPV
Symptoms: Antibody test abnormal, Pyrexia, Tenderness, Urticaria
Clinical narrative: PNEUMOVAX given 5/14/10. Fever developed 5/15/10. By 5/16/10 pt. had hives surrounding injection site, tenderness of upper arm, continued fever. No sign of viral illness. On abx fro chronic sinus infection (CLINDAMYCIN). No sign of local infection around injection site. Continues with fever 5/17/10.
Age: 76.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of drug administration, Wrong drug administered
Clinical narrative: Pt received second dose of HAVRIX at 1 month interval instead of 6 months. Was to have received Hepatitis B.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, PNC13
Symptoms: Gait disturbance, Pain
Clinical narrative: Pt limping since getting immunizations. RLE pain. No redness no swelling no hardness. Tx: Heat, elevate, ibuprofen.
Age: 1.68
Sex: M
Vaccine: FLU3, HEPA
Symptoms: Depressed level of consciousness, Hypotonia, Hypotonic-hyporesponsive episode
Clinical narrative: Apparent hypotonic reaction - note states "fell asleep in car" "seemed in a deeper sleep which she (mom) was unable to waken with pinching" "was limp and not rousing" "a few  minutes after putting in his crib he woke and now seems fully awake and acting normally".
Age: 9.0
Sex: M
Vaccine: HEPA
Symptoms: Vomiting
Clinical narrative: Vomiting - began several hours after vaccine given.
Age: 1.01
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Skin lesion
Clinical narrative: Seen 5/18/10 for itchy lesions on back. Approximately 30 lesions. Supportive treatment for symptoms advised.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Caesarean section, Drug exposure during pregnancy, Ultrasound scan abnormal
Clinical narrative: Information has been received from a nurse practitioner for GARDASIL, a Pregnancy Registry product, concerning a 24 years old female with no drug allergies and no pertinent medical history who on 06-NOV-2008 was vaccinated with the first dose of GARDASIL (lot number unknown). On 23-JAN-2009 the patient was vaccinated with the second dose of GARDASIL (lot number 661703/0651X). On 12-JUN-2009 the patient was vaccinated with the third dose of GARDASIL (lot number 661703/0651X). The patient became pregnant around the time of the 3rd dose GARDASIL. Pregnancy is normal to date. The patient's LMP was reported as 24-MAY-2009. The estimated delivered date would be on 28-FEB-2010. Follow-up information was received from the consumer via a completed outcome pregnancy questionnaire. It was reported that the patient did not have any previous pregnancies, pre-term deliveries, spontaneous abortions, elective terminations or fetal deaths. The estimated conception date was 11-MAY-2009. On 16-FEB-2010, the patient delivered a normal female baby with no congenital anomalies weighing 8 pounds, 7 ounces, length 20 inches. The patient had no complication and no infections or illnesses during pregnancy. It was reported that the baby was stuck, so the patient had to have a C-section. The patient had no concurrent medical conditions. Upon internal review, C-Section was determined to be an other important medical event. Subsequently, the baby experienced heart murmur. The baby's experience was captured in WAES#0907USA01322B1. Additional information has been requested.
Age: 20.0
Sex: M
Vaccine: FLU(H1N1), PPV
Symptoms: Feeling hot, Oedema peripheral, Pain in extremity
Clinical narrative: Pt said that his left arm started swelling up and getting warm with pain in the late evening. He did not take any prn analgesic.
Age: 0.44
Sex: M
Vaccine: HIBV, PNC13
Symptoms: Irritability, Pyrexia, Rash macular
Clinical narrative: Fussy, fever ~101, blotchy rash on back.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Drug exposure during pregnancy, Urine human chorionic gonadotropin positive
Clinical narrative: Patient received 1st dose of GARDASIL while pregnant. VFC questionnaire completed but as per pt's mother and older sister pt. did lie & withhold information. Pt instructed to follow up with OB clinic ASAP. This is in follow-up to report(s) previously submitted on 05/21/2010. No adverse reactions noted as of 6/9/10 clinic just wanted to notify CDC of incident.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abortion induced, Drug exposure before pregnancy
Clinical narrative: Patient received 1st dose of GARDASIL while pregnant. VFC questionnaire completed but as per pt's mother and older sister pt. did lie & withhold information. Pt instructed to follow up with OB clinic ASAP. This is in follow-up to report(s) previously submitted on 05/21/2010. No adverse reactions noted as of 6/9/10 clinic just wanted to notify CDC of incident.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, VARCEL
Symptoms: Condition aggravated, Injection site swelling, Oedema, Scab
Clinical narrative: 2d after vaccine, patient developed a bright red, edematous arm and eczema patches. R arm swelling resolved eczema has gotten worse and spread all over. R axilla and shoulder with some honey colored crust.
Age: 17.0
Sex: F
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site cellulitis, Injection site reaction
Clinical narrative: Pt had vaccine 5/5/10-returned to office on 5/7 with reaction on left arm at subq injection site. Dx'd as cellulitis by doctor vs reaction to immunization. Treated with ice to area and Keflex 500mg tid.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Bacterial test negative, Erythema, Oedema, Rash vesicular
Clinical narrative: 9 yo male with 15cm of erythema and edema and 3cm vesicular reaction after varicella vaccine administered 5-18-10.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Urticaria
Clinical narrative: Developing hives 5/20/2010 around 3 pm. BENADRYL prescribed no resp. distress.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Pruritus, Swelling, Urticaria
Clinical narrative: Pt was given PREVNAR 13, pt left clinic room within 5 minutes pt had welts under eyes, down face, ear lobe swelling, hives were itching. Pt was re-roomed. Dr was notified. No respiratory involvement. Pt was given 12.5 mg of BENADRYL and kept in clinic for 45 minutes. Pt left, hives were almost gone.
Age: 66.0
Sex: F
Vaccine: DT
Symptoms: Nausea, Skin warm, Vomiting
Clinical narrative: Patient experienced nausea and 2 accidents of vomiting about 12 hrs after vaccination. Possible mild fever - hadn't elevated but said she feels "warm".
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Rash generalised, Swelling face
Clinical narrative: facial swelling, generalized rash
Age: 1.05
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Erythema multiforme, Rash
Clinical narrative: Rash. Erythema Multiforme.
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Breast pain, Injection site pain, Limb discomfort, Non-cardiac chest pain, Pain in extremity
Clinical narrative: Pt received PPSV23 4-29-10, soon after receiving vaccine c/o pain @ site, rt deltoid. By 24 hours she reports that her right arm was twice its normal size, with pain across shoulders, neck & rt chest/breast. She had an OV 5-13-10 & con't to c/o pain/tenderness rt arm & rt deltoid area mildly swollen. She is able to move rt arm but is uncomfortable.
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Swelling, Tenderness
Clinical narrative: Pt received PPSV23 4-29-10, soon after receiving vaccine c/o pain @ site, rt deltoid. By 24 hours she reports that her right arm was twice its normal size, with pain across shoulders, neck & rt chest/breast. She had an OV 5-13-10 & con't to c/o pain/tenderness rt arm & rt deltoid area mildly swollen. She is able to move rt arm but is uncomfortable.
Age: 25.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered, Unevaluable event
Clinical narrative: None.  HAVRIX ped/adol dose given to adult.
Age: 32.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Injection site swelling, Musculoskeletal stiffness
Clinical narrative: Pain, swelling, stiffness at injection site - afebrile.  Ice applied.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Pain in extremity, Rash, Skin warm
Clinical narrative: Pt had Tdap 5/6/10 got states got redness and area firm below injection site, area on arm was sore and warm for couple of days on 5/11/10 pt reported minimal [pink rash 4x4 6 cm below site.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling, Injection site urticaria
Clinical narrative: On 4-7-10 large welts, itchy, hot, red swollen upper right arm shots DTAP, IPV, VARIVAX given in right arm on 3-23-10. Gave BENADRYL/TYLENOL - reaction gone in a day. Same reaction happened again 3-4 weeks later. Same treatment of BENADRYL  and TYLENOL. 3rd episode on 5-9-10 same treatment of BENADRYL/TYLENOL- next day.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site warmth
Clinical narrative: On 4-7-10 large welts, itchy, hot, red swollen upper right arm shots DTAP, IPV, VARIVAX given in right arm on 3-23-10. Gave BENADRYL/TYLENOL - reaction gone in a day. Same reaction happened again 3-4 weeks later. Same treatment of BENADRYL  and TYLENOL. 3rd episode on 5-9-10 same treatment of BENADRYL/TYLENOL- next day.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Rash erythematous, Rash papular, Rash pruritic, Swelling
Clinical narrative: Patient was noted to have pruritic, red, raised, rash on epigastric region few hours before seen in the office on 5/13/10. While waiting to be seen, the rashes were noted to spread to chest, abdomen, neck & arm, some like mosquito bites, others have fluid like papulo-vesicules. Patient received VARIVAX # 1 on 9/27/2005 & VARIVAX #2 on 10/23/2008.
Age: 29.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Acute disseminated encephalomyelitis, Asthenia, Ataxia, Dizziness, Drug exposure during pregnancy
Clinical narrative: 12/1/09 vaginal birth with no reported complications. Rh factor injection received during pregnancy. 1/10 food borne illness with no treatment. 1/10 not feeling well, left sided pain, pain with tactile stimulation that progressed to left sided numbness. 2/10 routine OB appointment still feeling bad. Diagnosed with PP depression. Rx Zoloft. 2/15/10 started Zoloft still felt dizzy. Ordered to stop Zoloft. 2/22/10 full body weakness. 2/24/10 went to ED and admitted as inpatient diagnosed with ataxia due to post infectious cerebritis. Reports received testing to rule out West Nile virus and herpes inpatient for 13 days. Then to inpatient rehab on 3/9/10. Received EEG and CT of brain at this time. Then diagnosed with acute disseminated encephalomyelitis (ADEM). 3/17/10 inpatient x 7 weeks. Received plasmapheresis. Now receiving ongoing rehab, immunosuppresive therapy and steroid treatments.
Age: 29.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Electroencephalogram, Encephalitis, Hypoaesthesia, Malaise, Pain
Clinical narrative: 12/1/09 vaginal birth with no reported complications. Rh factor injection received during pregnancy. 1/10 food borne illness with no treatment. 1/10 not feeling well, left sided pain, pain with tactile stimulation that progressed to left sided numbness. 2/10 routine OB appointment still feeling bad. Diagnosed with PP depression. Rx Zoloft. 2/15/10 started Zoloft still felt dizzy. Ordered to stop Zoloft. 2/22/10 full body weakness. 2/24/10 went to ED and admitted as inpatient diagnosed with ataxia due to post infectious cerebritis. Reports received testing to rule out West Nile virus and herpes inpatient for 13 days. Then to inpatient rehab on 3/9/10. Received EEG and CT of brain at this time. Then diagnosed with acute disseminated encephalomyelitis (ADEM). 3/17/10 inpatient x 7 weeks. Received plasmapheresis. Now receiving ongoing rehab, immunosuppresive therapy and steroid treatments.
Age: 29.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Plasmapheresis, Postpartum depression, Scan brain
Clinical narrative: 12/1/09 vaginal birth with no reported complications. Rh factor injection received during pregnancy. 1/10 food borne illness with no treatment. 1/10 not feeling well, left sided pain, pain with tactile stimulation that progressed to left sided numbness. 2/10 routine OB appointment still feeling bad. Diagnosed with PP depression. Rx Zoloft. 2/15/10 started Zoloft still felt dizzy. Ordered to stop Zoloft. 2/22/10 full body weakness. 2/24/10 went to ED and admitted as inpatient diagnosed with ataxia due to post infectious cerebritis. Reports received testing to rule out West Nile virus and herpes inpatient for 13 days. Then to inpatient rehab on 3/9/10. Received EEG and CT of brain at this time. Then diagnosed with acute disseminated encephalomyelitis (ADEM). 3/17/10 inpatient x 7 weeks. Received plasmapheresis. Now receiving ongoing rehab, immunosuppresive therapy and steroid treatments.
Age: 24.0
Sex: M
Vaccine: HEPAB
Symptoms: Erythema, Induration, Oedema peripheral, Skin warm
Clinical narrative: re raised warm area of induration 7.5 cm by 6cm well below site of injection on left arm
Age: 18.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache,cold chills,mild fever Treated with Tylenol Was given Augmentin 875mg BID
Age: 26.0
Sex: M
Vaccine: FLU(H1N1), PPV
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: 05/13/2000 W I c/o red, swollen and painful (L) arm day after receiving pneumonia shot. Ref to doctor after eval. Red, hot, tender 13 x 9 cm (L) tricep area.
Age: 62.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath-3 mo.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Oedema peripheral, Pain in extremity
Clinical narrative: Within 24 hours, arm pain at forearm with hard swelling and pain.  Injection was in upper arm.
Age: 1.06
Sex: M
Vaccine: FLU(H1N1), HEPA, MMR, VARCEL
Symptoms: Autopsy, Death, Endocardial fibroelastosis, Unresponsive to stimuli
Clinical narrative: Pt. received vaccines on 1/7/10 and was found unresponsive in crib on 1/28/10. Autopsy showed pt. died from Fibroelastosis of the heart.
Age: 12.0
Sex: F
Vaccine: PNC13
Symptoms: Hypersensitivity, Injection site pain, Injection site swelling, Type III immune complex mediated reaction
Clinical narrative: Pt in clinic 5/5/2010 and got a PREVNAR-13 shot. On Thursday, develop pain and swelling at injection site. Swelling worsened on Friday and was admitted to the hospital and tx w/ antibiotics for possible cellulitis? Per MD on exam, likely an arthus hypersensitivity reaction.
Age: 10.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Neck pain, Pain in extremity, Rash erythematous
Clinical narrative: Developed pain and stiffness in neck. Went to ER. Dx swollen lymph nodes in neck. Lasted 3-4 days. Rx -  ibuprofen prn. Also had red rash and pain L arm -  lower posterior area. Rash is fading at present.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria
Clinical narrative: Swelling, redness, hives at left deltoid muscle.  No fever or pain.  Mild itchiness at injection site.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site reaction, Injection site swelling
Clinical narrative: Swollen, warm local reactions of the injection site. Tdap tender indurated 100mm x 100mm redness 60 mm x 80mm tender. HPV site with tenderness extending 70mm x 40mm from injection site and redness 25mm x 25mm. MENACTRA site area of tenderness 30mm size.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site warmth
Clinical narrative: Swollen, warm local reactions of the injection site. Tdap tender indurated 100mm x 100mm redness 60 mm x 80mm tender. HPV site with tenderness extending 70mm x 40mm from injection site and redness 25mm x 25mm. MENACTRA site area of tenderness 30mm size.
Age: 0.21
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV1
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Mother reports mild-moderate redness & swelling @ injection site 2 days after vaccination. Treated with oral TYLENOL and cool compress to site.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Paranasal sinus hypersecretion, Pyrexia, Tonsillar hypertrophy
Clinical narrative: 5/19/10 at 11:38 AM employee contacted RN at Hospital regarding symptoms of fever and tonsil swelling. Also stated having sinus drainage. Concerned over reaction from vaccination received 5/18/10. Acknowledged concern. Request follow-up call 5/20/10. Unable to follow-up employee has not returned phone messages.
Age: 1.92
Sex: M
Vaccine: DTAP
Symptoms: Injection site swelling
Clinical narrative: Pt mother brought child in for a DTAP vaccine to catch up pt with immunization schedule. Pt mother stated she noticed swelling a days later.
Age: 64.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash erythematous
Clinical narrative: 5/3/10 11:00 am received MMR vaccination booster. Traveled to another state via air plane and back 5/13/10. Noted fever 102 degrees F and then a mild red dot rash on upper arms and trunk on 5/19/10. Notified doctor at hospital on 5/21/10 of symptoms.
Age: 13.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Incorrect dose administered, Unevaluable event
Clinical narrative: No adverse reaction - Extra MMR given.
Age: 10.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Incorrect dose administered, Unevaluable event
Clinical narrative: No adverse reaction. Extra MMR given.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Alanine aminotransferase increased, Arthralgia, Aspartate aminotransferase increased, Back pain, Chills
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Myalgia, Pyrexia
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Alanine aminotransferase, Aspartate aminotransferase, Back pain, Chills, Differential white blood cell count
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Full blood count, Headache, Hyperhidrosis, Pyrexia, Urine analysis
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Age: 37.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Weight decreased
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 37-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 12 May 2010 at 12:00 the subject received 1st dose of HAVRIX (1 ml, unknown route, left arm). On 14 May 2010, 2 days after vaccination with HAVRIX, the subject experienced fever, chills, low back pain, arthralgia and myalgia. He also experienced elevated alanine aminotransferase (ALT) and elevated aspartate aminotransferase (AST). The physician considered the events were disabling. Relevant test results included: baseline labs, ALT (61, units not provided) and AST (24, units not provided) levels on 12 May 2010 were normal. On an unspecified date, ALT increased to 118 (normal range 30-65) and AST increased to 79 (normal range 15-37). At the time of reporting the events were unresolved. The vaccination course with HAVRIX was discontinued. It was reported that due to the events, the subject did not wish to have any other vaccinations.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Pruritus, Rash macular, Urticaria
Clinical narrative: Woke up with welts and red splotches on abd, arms and back.  + itching.
Age: 77.0
Sex: F
Vaccine: TD, TD
Symptoms: Asthenia, Blood creatine phosphokinase normal, Blood electrolytes normal, Fatigue
Clinical narrative: Pulsating sensations in arms and legs. Also repoted feeling weak and tired. Few days later developed constricting sensation in calves and forearms.  Gets relief of symptoms by walking.
Age: 77.0
Sex: F
Vaccine: TD, TD
Symptoms: Balance disorder, Blood potassium, Blood sodium, Fatigue, Heart rate increased
Clinical narrative: Pulsating sensations in arms and legs. Also repoted feeling weak and tired. Few days later developed constricting sensation in calves and forearms.  Gets relief of symptoms by walking.
Age: 77.0
Sex: F
Vaccine: TD, TD
Symptoms: Muscle disorder, Muscular weakness, Renal disorder, Vasoconstriction
Clinical narrative: Pulsating sensations in arms and legs. Also repoted feeling weak and tired. Few days later developed constricting sensation in calves and forearms.  Gets relief of symptoms by walking.
Age: 6.0
Sex: M
Vaccine: DTAP
Symptoms: Chest pain, Rash erythematous
Clinical narrative: THREE RED BUMPS ON HIS CHEST, LIKE MOSQUITO BITES. COMPLAINING OF PAIN IN CHEST UNDER WHERE THE BUMPS ARE LOCATED.
Age: 46.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Joint stiffness, Metabolic function test, Platelet count normal, Vasculitis, White blood cell count normal
Clinical narrative: Joint stiffness and vasculitis development after time. Tx. IV hydration and analgesia.
Age: 1.03
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Rash developed in pelvic area and buttocks.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Antinuclear antibody, Blood electrolytes, Blood glucose, C-reactive protein, Chills
Clinical narrative: Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Dyspnoea, Fatigue, Feeling abnormal, Hypoaesthesia
Clinical narrative: Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Insomnia, Memory impairment, Metabolic function test, Migraine, Muscle spasms
Clinical narrative: Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Muscle twitching, Muscular weakness, Night sweats, Pain, Paraesthesia
Clinical narrative: Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Red blood cell sedimentation rate, Renal function test
Clinical narrative: Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, PNC13, VARCEL
Symptoms: Erythema, Local reaction, Skin warm
Clinical narrative: Skin red and warm to touch there is no drainage or hardness presented. Applied cool pack to site. Dr assessed site and stated it looked like a local reaction. She couseled pt mother and told her to return tp the clinic or emergency room if redness spread or patient developed fever.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV
Symptoms: Cellulitis
Clinical narrative: Cellulitis
Age: 60.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Anaphylactic reaction, Bronchospasm, Pruritus, Rash, Urticaria
Clinical narrative: Rash, itching.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Redness, swelling and increased warmth at site of injection. Redness - 12cm x 10cm.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Dyspnoea, Pruritus, Tachycardia
Clinical narrative: SOB-tachycardia-itching-almost fainted 24 hours later-delayed rxn. Arm still itching and taking Benadryl.
Age: 12.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site haematoma
Clinical narrative: Right deltoid area he has area of erythema 5x5 cm and adjacent there is a bruise 2x2 cm.
Age: 55.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Culture throat, Full blood count, Joint stiffness, Lymphadenopathy, Pyrexia
Clinical narrative: Received MMR 5-5-10. had (L) axillary adenopathy, fever 99-102, rash, stiff joints-sudden onset-5-14-10.
Age: 55.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Rash
Clinical narrative: Received MMR 5-5-10. had (L) axillary adenopathy, fever 99-102, rash, stiff joints-sudden onset-5-14-10.
Age: 46.0
Sex: M
Vaccine: TDAP
Symptoms: Cellulitis, Erythema, Skin warm, Tenderness
Clinical narrative: Redness and tenderness started 5/18/10. Seen in office today. Has 5"x6.5" erythema and hot to touch. Rx with ABX. Reaction below site of injection according to pt. Rx with KEFLEX 500 mg, 2 caps BID x7 days.
Age: 71.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness/swelling/pain at injection site (L) deltoid. Doxycycline - cold compresses.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Electromyogram abnormal, Myalgia, Nerve conduction studies abnormal, Pyrexia
Clinical narrative: I was ill the first three weeks of December with a headache, fever about 100 degrees, upper back pain and fatigue.  On December 28, 2009, I discovered tingling in the bottom of my feet and weakness in legs after taking my morning shower.  My body got progressively weak as the day went on.  I was admitted to hospital on December 28, 2009.  By December 29, 2009, I was barely able to lift my arms and legs.  I could not get out of the bed to use the bathroom and had to use a bed pan.  I received five immunoglobulin treatments over the course of a week.  I was transferred to another hospital on January 5, 2010. I received physical and occupational therapy for about a week and a half.  I suffered from vomiting and developed tachycardia.  I was rushed to hospital on January 10, 2010.  I received five days of immunoglobulin treatment.  I did not improve, so I was transferred to another hospital on January 21, 2010.  I was given five days of plasmapheresis treatment and finally stabilized.  I was transferred to a rehabilitation hospital on February 2, 2010 occupational and physical therapy.  I was just learning how to walk and experienced a relapse.  I was transferred back to hospital for another five days of plasmapheresis treatment.  I was released to rehabilitation hospital on March 4, 2010 for occupational and physical therapy.  I was discharged on 3/19/10.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Back pain, Fatigue, Headache, Immobile
Clinical narrative: I was ill the first three weeks of December with a headache, fever about 100 degrees, upper back pain and fatigue.  On December 28, 2009, I discovered tingling in the bottom of my feet and weakness in legs after taking my morning shower.  My body got progressively weak as the day went on.  I was admitted to hospital on December 28, 2009.  By December 29, 2009, I was barely able to lift my arms and legs.  I could not get out of the bed to use the bathroom and had to use a bed pan.  I received five immunoglobulin treatments over the course of a week.  I was transferred to another hospital on January 5, 2010. I received physical and occupational therapy for about a week and a half.  I suffered from vomiting and developed tachycardia.  I was rushed to hospital on January 10, 2010.  I received five days of immunoglobulin treatment.  I did not improve, so I was transferred to another hospital on January 21, 2010.  I was given five days of plasmapheresis treatment and finally stabilized.  I was transferred to a rehabilitation hospital on February 2, 2010 occupational and physical therapy.  I was just learning how to walk and experienced a relapse.  I was transferred back to hospital for another five days of plasmapheresis treatment.  I was released to rehabilitation hospital on March 4, 2010 for occupational and physical therapy.  I was discharged on 3/19/10.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Immunoglobulin therapy, Lumbar puncture, Malaise, Mobility decreased, Muscular weakness
Clinical narrative: I was ill the first three weeks of December with a headache, fever about 100 degrees, upper back pain and fatigue.  On December 28, 2009, I discovered tingling in the bottom of my feet and weakness in legs after taking my morning shower.  My body got progressively weak as the day went on.  I was admitted to hospital on December 28, 2009.  By December 29, 2009, I was barely able to lift my arms and legs.  I could not get out of the bed to use the bathroom and had to use a bed pan.  I received five immunoglobulin treatments over the course of a week.  I was transferred to another hospital on January 5, 2010. I received physical and occupational therapy for about a week and a half.  I suffered from vomiting and developed tachycardia.  I was rushed to hospital on January 10, 2010.  I received five days of immunoglobulin treatment.  I did not improve, so I was transferred to another hospital on January 21, 2010.  I was given five days of plasmapheresis treatment and finally stabilized.  I was transferred to a rehabilitation hospital on February 2, 2010 occupational and physical therapy.  I was just learning how to walk and experienced a relapse.  I was transferred back to hospital for another five days of plasmapheresis treatment.  I was released to rehabilitation hospital on March 4, 2010 for occupational and physical therapy.  I was discharged on 3/19/10.